Revelation Biosciences In...

NASDAQ: REVB · Real-Time Price · USD
2.57
-0.01 (-0.39%)
At close: Aug 15, 2025, 3:51 PM
2.60
1.33%
After-hours: Aug 15, 2025, 07:36 PM EDT

Revelation Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
26.96K 26.96K 26.96K 37.57K 37.57K 37.57K 37.57K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
35.14K 35.14K 34.18K 39.49K 38.53K 37.57K 37.57K 25.05K 25.05K 25.05K 40.01K 54.66K 68.81K 77.25K 66K 45.09K 24.68K 9.97K
Gross Profit
-8.18K -8.18K -7.22K -1.92K -957 1.00 n/a -25.05K -25.05K -25.05K -40.01K -54.66K -68.81K -77.25K -66K -45.09K -24.68K -9.97K
Operating Income
-8.11M -8.17M -7.97M -8.55M -9.53M -8.94M -8.66M -7.55M -5.97M -5.9M -10.86M -13.5M -15.35M -15.93M -11.95M -10.99M -7.95M -5.5M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a 28.73K 28.73K 28.73K 28.73K n/a n/a n/a 10.91K 10.91K 10.91K
Pretax Income
-11.65M -14.41M -15.04M -15.52M -15.9M -8.96M -120K 875K 2.33M 1.95M -10.83M -13.48M -15.36M -15.99M -11.99M -11.02M -7.98M -5.67M
Net Income
-8.46M -14.41M -15.04M -15.52M -15.9M -8.96M -120K 875K 2.33M 1.95M -10.83M -13.48M -15.36M -15.99M -11.99M -9.58M -6.54M -4.07M
Selling & General & Admin
4.49M 4.48M 4.43M 4.54M 4.71M 4.6M 4.51M 4.12M 3.82M 3.68M 5.49M 5.8M 6.49M 6.89M 5.04M 4.72M 3.21M 2M
Research & Development
3.61M 3.69M 3.55M 4M 4.82M 4.34M 4.15M 3.43M 2.16M 2.22M 5.38M 7.7M 8.85M 9.04M 6.91M 6.27M 4.74M 3.67M
Other Expenses
980.00 980.00 228.00 -268 -582 -860 -551 -878 -878 -1.02K -747 -420 -420 n/a n/a -891 -891 -891
Operating Expenses
8.11M 8.17M 7.97M 8.55M 9.53M 8.94M 8.66M 7.55M 5.97M 5.9M 10.86M 13.5M 15.35M 15.93M 11.95M 10.99M 7.94M 5.67M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 41.76K 42.32K 42.32K 42.32K 557.00 n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.11M 8.17M 7.97M 8.55M 9.53M 8.94M 8.66M 7.55M 5.97M 5.9M 10.86M 13.5M 15.35M 15.93M 11.95M 10.99M 7.94M 5.67M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -32.91K -32.91K -32.91K -32.91K 126.00 -52.62K -52.62K
Shares Outstanding (Basic)
802.67K 971.31K 346.5K 167.5K 102.2K 68.11K 16.53K 13.12K 12.11K 4.61K 1.42K 1.25K 897.78 845.35 587.59 374.51 374.51 374.42
Shares Outstanding (Diluted)
802.67K 971.31K 346.5K 167.5K 102.2K 68.11K 16.53K 13.12K 12.11K 6.53K 1.42K 1.25K 897.78 845.35 587.59 374.51 374.51 374.42
EPS (Basic)
-27.48 -102.56 -139.82 -268.08 -455.04 -492.55 884.14 168.64 -565.1 -2.49K -11.65K -17.37K -24.57K -29.12K -28.27K -24.67K -16.54K -9.91K
EPS (Diluted)
-27.48 -102.56 -139.82 -268.08 -455.04 -492.55 489.58 -225.92 -959.66 -2.88K -11.65K -17.37K -24.57K -29.12K -28.27K -24.67K -16.54K -9.94K
EBITDA
-8.09M -8.14M -7.95M -8.52M -9.5M -8.91M -8.63M -7.53M -5.95M -5.87M -10.84M -13.48M -15.32M -15.91M -11.93M -8.21M -5.17M -2.57M
EBIT
-8.09M -8.17M -7.97M -8.55M -9.53M -8.94M -8.66M -7.55M -5.97M -5.9M -10.86M -13.5M -15.35M -15.93M -11.95M -10.99M -7.95M -5.5M
Depreciation & Amortization
28.88K 28.88K 27.92K 26.96K 26.01K 25.05K 25.05K 25.05K 25.05K 25.05K 25.05K 25.05K 24.86K 22.4K 16.78K -207.11K -213.18K -52.11K